CAS 1610964-64-1

Unesbulin

CAS : 1610964-64-1

Unesbulin (PTC596) is an orally active and selective inhibitor of B-cell-specific Moloney murine leukemia virus integration site 1 (BMI-1).

Formule : C₁₉H₁₃F₅N₆

Degré de pureté : 98.71%

Couleur et forme : Solid

Masse moléculaire : 420.34

Ref: TM-T12575

5-fluoro-2-(6-fluoro-2-methyl-1H-benzimidazol-1-yl)-N⁴-[4-(trifluoromethyl)phenyl]-4,6-pyrimidinediamine

CAS : 1610964-64-1

Formule : C₁₉H₁₃F₅N₆

Degré de pureté : %

Couleur et forme : Solid

Masse moléculaire : 420.3387

Ref: IN-DA01LIAP

5-Fluoro-2-(6-Fluoro-2-Methyl-1H-Benzo[D]Imidazol-1-Yl)-N4-(4-(Trifluoromethyl)Phenyl)Pyrimidine-4,6-Diamine

CAS : 1610964-64-1

5-Fluoro-2-(6-Fluoro-2-Methyl-1H-Benzo[D]Imidazol-1-Yl)-N4-(4-(Trifluoromethyl)Phenyl)Pyrimidine-4,6-Diamine

Degré de pureté : 98+%

Masse moléculaire : 420.34g/mol

Ref: 54-PC108595

Unesbulin

CAS : 1610964-64-1

Unesbulin

Degré de pureté : ≥98%

Masse moléculaire : 420.34g/mol

Ref: 54-BUP01583

5-Fluoro-2-(6-fluoro-2-methyl-1H-benzo[d]imidazol-1-yl)-N4-(4-(trifluoromethyl)phenyl)pyrimidine-4,6-diamine

CAS : 1610964-64-1

Formule : C₁₉H₁₃F₅N₆

Degré de pureté : 98+%

Masse moléculaire : 420.347

Ref: 10-F546699

PTC596

CAS : 1610964-64-1

PTC596 is a histidine-based molecule that has been shown to induce apoptotic cell death in cancer cells, including murine leukemia. PTC596 is undergoing clinical development for the treatment of cancer and other diseases. It has synergistic effects with anticancer drugs and hematopoietic cells, which may be due to its ability to induce mitochondrial membrane potential and angiogenic factors. PTC596 also inhibits the growth of various types of cancer stem cells.

Formule : C₁₉H₁₃F₅N₆

Degré de pureté : Min. 95%

Masse moléculaire : 420.3 g/mol

Ref: 3D-KPC96464